Piper Sandler & Co’s Transmedics TMDX Stock Holding History

Piper Sandler & Co’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,000	Closed	-$870K	–	26
2019 Q2	$870K	Buy	+30,000	New	+$819K	1.15%	9

Other funds holding TMDX

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Piper Sandler & Co's TMDX Position: Q3 2019 in Review

Piper Sandler & Co sold out of Transmedics (TMDX) in Q3 2019, closing a stake of 30,000 shares — an estimated $870K sold.

Piper Sandler & Co first reported a position in TMDX in Q2 2019 and held it in 1 quarter. The position peaked at $870K in Q2 2019. 50 funds tracked by Wall St. Rank hold TMDX as of Q3 2019.

Piper Sandler & Co reported no remaining Transmedics position as of Q3 2019 after selling out during the quarter.
Piper Sandler & Co sold 30,000 Transmedics shares in Q3 2019, an estimated $870K.
Piper Sandler & Co first reported a position in Transmedics in Q2 2019 and held it in 1 quarter.
Piper Sandler & Co's Transmedics position peaked at $870K in Q2 2019.
50 funds tracked by Wall St. Rank held Transmedics as of Q3 2019.

Based on Piper Sandler & Co's 13F filing for Q3 2019, filed 14 Nov 2019.